Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors
- PMID: 19848604
- DOI: 10.1086/648083
Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors
Abstract
Objective: Healthcare-associated infections are likely to be caused by drug-resistant and possibly mixed organisms and to be treated with inappropriate antibiotics. Because prompt appropriate treatment is associated with better outcomes, we studied the epidemiology of healthcare-associated complicated skin and skin-structure infections (cSSSIs).
Patients: Persons hospitalized with cSSSI and a positive culture result.
Methods: We conducted a single-center retrospective cohort study from April 2006 through December 2007. We differentiated healthcare-associated from community-acquired cSSSIs by at least 1 of the following risk factors: (1) recent hospitalization, (2) recent antibiotics, (3) hemodialysis, and (4) transfer from a nursing home. Inappropriate treatment was defined as no antimicrobial therapy with activity against the offending pathogen(s) within 24 hours after collection of a culture specimen. Mixed infections were those caused by both a gram-positive and a gram-negative organism.
Results: Among 717 hospitalized patients with cSSSI, 527 (73.5%) had healthcare-associated cSSSI. Gram-negative organisms were more common (relative risk, 1.24 [95% confidence interval, 1.14-1.35) and inappropriate treatment trended toward being more common (odds ratio, 1.29 [95% confidence interval, 0.85-1.95]) in healthcare-associated cSSSI than in community-acquired cSSSI. Mixed cSSSIs occurred in 10.6% of patients with healthcare-associated cSSSI and 6.3% of those with community-acquired cSSSI (P = .082) and were more likely to be treated inappropriately than to be nonmixed infections (odds ratio, 2.42 [95% confidence interval, 1.43-4.10]). Both median length of hospital stay (6.2 vs 2.9 days; P < .001) and mortality rate (6.6% vs 1.1%; P = .003) were significantly higher for healthcare-associated cSSSI than community-acquired cSSSI.
Conclusions: Healthcare-associated cSSSIs are common and are likely to be caused by gram-negative organisms. Mixed infections carry a >2-fold greater risk of inappropriate treatment. Healthcare-associated cSSSIs are associated with increased mortality and prolonged length of hospital stay, compared with community-acquired cSSSIs.
Similar articles
-
Risk factors for mixed complicated skin and skin structure infections to help tailor appropriate empiric therapy.Surg Infect (Larchmt). 2012 Dec;13(6):377-82. doi: 10.1089/sur.2011.101. Epub 2012 Dec 10. Surg Infect (Larchmt). 2012. PMID: 23216526
-
Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes.J Hosp Med. 2010 Nov-Dec;5(9):535-40. doi: 10.1002/jhm.713. Epub 2010 Aug 23. J Hosp Med. 2010. PMID: 20734456
-
Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.Surg Infect (Larchmt). 2005 Fall;6(3):283-95. doi: 10.1089/sur.2005.6.283. Surg Infect (Larchmt). 2005. PMID: 16201938 Review.
-
Between community and hospital: healthcare-associated gram-negative bacteremia among hospitalized patients.Infect Control Hosp Epidemiol. 2009 Nov;30(11):1050-6. doi: 10.1086/606165. Infect Control Hosp Epidemiol. 2009. PMID: 19803723
-
The efficacy and safety of ceftobiprole in the treatment of complicated skin and skin structure infections: evidence from 2 clinical trials.Diagn Microbiol Infect Dis. 2008 May;61(1):103-9. doi: 10.1016/j.diagmicrobio.2008.03.004. Epub 2008 Apr 2. Diagn Microbiol Infect Dis. 2008. PMID: 18384998 Review.
Cited by
-
Impact of Gram-Negative Bacilli Resistance Rates on Risk of Death in Septic Shock and Pneumonia.Open Forum Infect Dis. 2024 Apr 26;11(5):ofae219. doi: 10.1093/ofid/ofae219. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38770211 Free PMC article.
-
Pillars for prevention and control of healthcare-associated infections: an Italian expert opinion statement.Antimicrob Resist Infect Control. 2022 Jun 20;11(1):87. doi: 10.1186/s13756-022-01125-8. Antimicrob Resist Infect Control. 2022. PMID: 35725502 Free PMC article. Review.
-
Characterization of Silver Resistance and Coexistence of sil Operon with Antibiotic Resistance Genes Among Gram-Negative Pathogens Isolated from Wound Samples by Using Whole-Genome Sequencing.Infect Drug Resist. 2022 Mar 31;15:1425-1437. doi: 10.2147/IDR.S358730. eCollection 2022. Infect Drug Resist. 2022. PMID: 35392367 Free PMC article.
-
Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics.J Antimicrob Chemother. 2021 Nov 22;76(Suppl 4):iv9-iv22. doi: 10.1093/jac/dkab351. J Antimicrob Chemother. 2021. PMID: 34849999 Free PMC article.
-
Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections.J Antimicrob Chemother. 2021 Nov 22;76(Suppl 4):iv2-iv8. doi: 10.1093/jac/dkab350. J Antimicrob Chemother. 2021. PMID: 34849996 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
